European Organisation for Research and Treatment of Cancer shared a post on X about a recent paper by Ramon Yarza et al. published in the International Journal of Gynecological Cancer:
“A new EORTC meta-analysis of 20 studies highlights the potential of progression-free survival as a surrogate endpoint for overall survival in advanced cervical carcinoma, especially in chemoimmunotherapy trials.”
Authors: Ramon Yarza, Melpomeni Kountouri, Helena Guedes, Catherine O’Gorman, Jose Manuel Estrada-Lorenzo, Corneel Coens, Judith Kroep, Fernanda Herrera, Ainhoa Madariaga.
More posts featuring EORTC.